Koller turns AI on drug discovery with newco insitro

Former Calico Life Sciences LLC Chief Computing Officer Daphne Koller has set her sights on modernizing the drug discovery process through her new venture, insitro Inc. (Menlo Park, Calif.). The company has secured undisclosed capital from  Arch Venture Partners, Foresite Capital, Andreessen Horowitz, GV and Third Rock Ventures.

In a blog post Wednesday, Koller said insitro plans to use big data to train machine learning models to address problems in the drug discovery and development process...